Comparison between Anthem Biosciences IPO and Fujiyama Power Systems IPO.
Anthem Biosciences IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Fujiyama Power Systems IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Anthem Biosciences IPO is up to ₹3,395.00 Cr whereas the issue size of the Fujiyama Power Systems IPO is up to ₹828.00 Cr. The final issue price of Anthem Biosciences IPO is ₹570.00 per share and of Fujiyama Power Systems IPO is ₹228.00 per share.
| Anthem Biosciences IPO | Fujiyama Power Systems IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹1 per share |
| Issue Price (Lower) | ₹540.00 per share | ₹216.00 per share |
| Issue Price (Upper) | ₹570.00 per share | ₹228.00 per share |
| Issue Price (Final) | ₹570.00 per share | ₹228.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ₹50.00 per share | |
| Market Lot Size | 26 shares | 65 shares |
| Fresh Issue Size | 0 shares | 2,63,15,789 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹600.00 Cr |
| OFS Issue Size | 5,95,75,319 shares | 1,00,00,000 shares |
| OFS Issue Size (Amount) | up to ₹3,395.00 Cr | up to ₹228.00 Cr |
| Issue Size Total | 5,95,75,319 shares | 3,63,15,789 shares |
| Issue Size Total (Amount) | up to ₹3,395.00 Cr | up to ₹828.00 Cr |
Anthem Biosciences IPO opens on Jul 14, 2025, while Fujiyama Power Systems IPO opens on Nov 13, 2025. The closing date of Anthem Biosciences IPO and Fujiyama Power Systems IPO is Jul 16, 2025, and Nov 17, 2025, respectively.
| Anthem Biosciences IPO | Fujiyama Power Systems IPO | |
|---|---|---|
| Anchor Bid Date | Jul 11, 2025 | Nov 12, 2025 |
| Issue Open | Jul 14, 2025 | Nov 13, 2025 |
| Issue Close | Jul 16, 2025 | Nov 17, 2025 |
| Basis Of Allotment (Tentative) | Jul 17, 2025 | Nov 18, 2025 |
| Initiation of Refunds (Tentative) | Jul 18, 2025 | Nov 19, 2025 |
| Credit of Share (Tentative) | Jul 18, 2025 | Nov 19, 2025 |
| Listing date (Tentative) | Jul 21, 2025 | Nov 20, 2025 |
| Anchor Lockin End date 1 | Aug 15, 2025 | Dec 17, 2025 |
| Anchor Lockin End date 2 | Oct 14, 2025 | Feb 15, 2026 |
Anthem Biosciences IPO P/E ratio is 70.62, as compared to Fujiyama Power Systems IPO P/E ratio of 40.85.
| Anthem Biosciences IPO | Fujiyama Power Systems IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Anthem Biosciences Ltd.'s revenue increased by 30% and profit after tax (PAT) rose by 23% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)Fujiyama Power Systems Ltd.'s revenue increased by 67% and profit after tax (PAT) rose by 245% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 76.87 | 99.67 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 74.68 | 87.88 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 70.62 | 40.85 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹31867.39 Cr. | ₹6986.17 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 20.82% | 39.40% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 26.88% | 41.01% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.05 | 0.87 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹8.07 | ₹5.58 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 20.82% | 39.40% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Anthem Biosciences IPO Retail Individual Investors (RII) are offered 2,07,95,834 shares while in Fujiyama Power Systems IPO retail investors are offered 2,07,95,834 shares. Qualified Institutional Buyers (QIB) are offered 1,18,83,333 shares in Anthem Biosciences IPO and 72,19,298 shares in Fujiyama Power Systems IPO.
| Anthem Biosciences IPO | Fujiyama Power Systems IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,78,24,999 shares | 1,08,28,947 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 1,18,83,333 shares | 72,19,298 shares |
| NII | 89,12,500 shares | 54,14,474 shares |
| RII | 2,07,95,834 shares | 1,26,33,772 shares |
| Employee | 1,58,653 shares | 2,19,298 shares |
| Others | ||
| Total | 5,95,75,319 shares | 3,63,15,789 shares |
Anthem Biosciences IPO subscribed 67.42x in total, whereas Fujiyama Power Systems IPO subscribed 2.21x.
| Anthem Biosciences IPO | Fujiyama Power Systems IPO | |
|---|---|---|
| QIB (times) | 192.80x | 5.24x |
| NII (times) | 44.70x | 0.92x |
| Big NII (times) | 51.66x | 0.56x |
| Small NII (times) | 30.80x | 1.63x |
| RII (times) | 5.98x | 1.05x |
| Employee (times) | 6.99x | 1.55x |
| Other (times) | ||
| Total (times) | 67.42x | 2.21x |
